Hypertension Research最新文献_第9页

Evaluation of public health and economic impacts of dietary salt reduction initiatives on social security expenditures for cardiovascular disease control in Japan 评估日本减少饮食盐对心血管疾病控制社会保障支出的公共卫生和经济影响。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-17 DOI: 10.1038/s41440-025-02108-z

Nayu Ikeda, Miwa Yamaguchi, Ikuko Kashino, Takehiro Sugiyama, Katsuyuki Miura, Nobuo Nishi

引用次数: 0

Correction: Impact of smoking status on incident hypertension in a Japanese occupational population 更正：吸烟状况对日本职业人群高血压发病率的影响。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-17 DOI: 10.1038/s41440-025-02158-3

Ikumi Yamato, Yasuo Kansui, Kiyoshi Matsumura, Minako Inoue, Ai Ibaraki, Satoko Sakata, Hisatomi Arima, Kenichi Goto, Takanari Kitazono

引用次数: 0

Impact of patient care teams on blood pressure control in patients with hypertension: a systematic review and meta-analysis. 患者护理团队对高血压患者血压控制的影响：系统回顾和荟萃分析。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-17 DOI: 10.1038/s41440-025-02152-9

Yuichi Akasaki, Yasunori Suematsu, Kengo Azushima, Yuhei Shiga, Atsushi Sakima, Michihiro Satoh, Hisatomi Arima, Nobuhito Hirawa

{"title":"Impact of patient care teams on blood pressure control in patients with hypertension: a systematic review and meta-analysis.","authors":"Yuichi Akasaki, Yasunori Suematsu, Kengo Azushima, Yuhei Shiga, Atsushi Sakima, Michihiro Satoh, Hisatomi Arima, Nobuhito Hirawa","doi":"10.1038/s41440-025-02152-9","DOIUrl":"https://doi.org/10.1038/s41440-025-02152-9","url":null,"abstract":"Hypertension is a significant risk factor for cardiovascular diseases, with its global prevalence doubling over the past three decades. Despite advancements in antihypertensive therapies, approximately 50% of patients with hypertension fail to achieve their target blood pressure (BP) levels, underscoring the need for innovative care strategies. Patient care teams comprising multidisciplinary healthcare providers have shown promise in improving BP management. This systematic review and meta-analysis were aimed at evaluating the effectiveness of patient care teams involving physicians in hypertension management. To this end, PubMed, Cochrane CENTRAL, and IchuShi-Web were comprehensively searched and 61 randomized controlled trials including 64,857 participants were identified. Compared with usual care, interventions by patient care teams significantly reduced office systolic BP (mean difference: -6.31 mmHg; 95% confidence interval: -7.71 to -4.90) and decreased the risk of uncontrolled BP by 27% (risk ratio: 0.73; 95% confidence interval: 0.68-0.79). Subgroup analyses demonstrated consistent BP reductions across various team leadership roles, such as physicians, nurses, and pharmacists, and across different intervention durations. These findings highlight the effectiveness of team-based BP management in achieving improved BP control, regardless of team composition or the follow-up period. Multidisciplinary care offers a viable approach to addressing the unmet needs of patients with hypertension, potentially improving cardiovascular outcomes. This evidence supports integrating patient care teams into hypertension management, particularly in settings requiring physician oversight. Future research should focus on refining team structures and tailoring interventions to diverse healthcare environments to enhance their impact.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":" ","pages":""},"PeriodicalIF":4.3,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143440743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Nighttime phenotype in patients with heart failure: beat-to-beat blood pressure variability predicts prognosis 心力衰竭患者的夜间表型：搏动血压变异性预测预后。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-17 DOI: 10.1038/s41440-025-02156-5

Hiromitsu Sekizuka

引用次数: 0

The importance of hypertension awareness and adequate blood pressure control before intracerebral hemorrhage 脑出血前高血压意识及适当血压控制的重要性。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-17 DOI: 10.1038/s41440-025-02161-8

Hajime Ikenouchi

引用次数: 0

Exploring the impact of cerebral small vessel disease on long-term prognosis in spontaneous intracerebral hemorrhage 探讨小血管病变对自发性脑出血患者长期预后的影响。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-14 DOI: 10.1038/s41440-025-02150-x

Naruhiko Kamogawa

引用次数: 0

Correction: Effects of renal denervation on the kidney: albuminuria, proteinuria, and renal function 修正：肾去神经支配对肾脏的影响：蛋白尿、蛋白尿和肾功能。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-14 DOI: 10.1038/s41440-025-02148-5

Daisuke Yamazaki, Yoshio Konishi, Kento Kitada

引用次数: 0

Efficacy of renin-angiotensin system inhibitors, calcium channel blockers, and diuretics in hypertensive patients with diabetes: subgroup analysis based on albuminuria in a systematic review and meta-analysis. 肾素-血管紧张素系统抑制剂、钙通道阻滞剂和利尿剂对高血压合并糖尿病患者的疗效：基于蛋白尿的亚组分析，一项系统评价和荟萃分析。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-14 DOI: 10.1038/s41440-025-02146-7

Daisuke Ichikawa, Wakako Kawarazaki, Sanae Saka, Tomohiko Kanaoka, Hirofumi Ohnishi, Hisatomi Arima, Shigeru Shibata

{"title":"Efficacy of renin-angiotensin system inhibitors, calcium channel blockers, and diuretics in hypertensive patients with diabetes: subgroup analysis based on albuminuria in a systematic review and meta-analysis.","authors":"Daisuke Ichikawa, Wakako Kawarazaki, Sanae Saka, Tomohiko Kanaoka, Hirofumi Ohnishi, Hisatomi Arima, Shigeru Shibata","doi":"10.1038/s41440-025-02146-7","DOIUrl":"https://doi.org/10.1038/s41440-025-02146-7","url":null,"abstract":"In hypertensive patients with diabetes, the effectiveness of renin-angiotensin system (RAS) inhibitors in improving mortality, cardiovascular events, and renal outcomes, compared to other antihypertensive drugs such as calcium channel blockers (CCBs) and diuretics, remains uncertain, particularly in the context of albuminuria. A comprehensive literature search was conducted using PubMed, the Cochrane Library, and the Japan Medical Abstracts Society databases up to October 2024. A meta-analysis of 12 randomized controlled trials, including 14,163 patients, was performed. RAS inhibitors showed no significant advantage over CCBs or diuretics for all-cause mortality (relative risk [RR]: 1.00, 95% confidence interval [CI]: 0.92-1.08, p = 0.98), myocardial infarction (RR: 0.64, 95% CI: 0.32-1.31, p = 0.22), stroke (RR: 1.14, 95% CI: 1.00-1.31, p = 0.05), composite cardiovascular events (RR: 0.93, 95% CI: 0.81-1.07, p = 0.45), or end-stage renal disease (RR: 0.88, 95% CI: 0.72-1.08, p = 0.21). Subgroup analyses stratified by albuminuria status revealed no significant benefits of RAS inhibitors, regardless of albuminuria presence. The findings emphasize the need for cautious interpretation due to limited sample sizes, wide confidence intervals, and low precision. These results highlight the importance of considering not only RAS inhibitors but also other antihypertensive drugs as the first-line choice for blood pressure control in diabetic patients, with careful attention to side effects and other relevant factors.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":" ","pages":""},"PeriodicalIF":4.3,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143425328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

How potassium intake regulates sodium excretion in the kidney? Aldosterone-independent pathway in human 钾的摄入如何调节肾内钠的排泄？人醛固酮非依赖性通路。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-14 DOI: 10.1038/s41440-025-02154-7

Hiromi Nakagawa, Emiko Kuribayashi-Okuma, Miho Inaba, Natsuki Sasadate, Takahiro Suzuki, Shigeru Shibata, Tatsuo Shimosawa

引用次数: 0

Correction: Clinical studies in Myxomatous Mitral Valve Disease dogs: most prescribed ACEI inhibits ACE2 enzyme activity and ARB increases AngII pool in plasma 更正：二尖瓣黏液瘤病犬的临床研究：大多数处方ACEI抑制ACE2酶活性，ARB增加血浆AngII池。

IF 4.3 2区医学

Hypertension Research Pub Date : 2025-02-14 DOI: 10.1038/s41440-025-02157-4

Smruti K. Nair, Elliot V. Hersh, Kenneth B. Margulies, Henry Daniell

引用次数: 0